Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Short term Debt (2017 - 2020)

Vycor Medical has reported Short term Debt over the past 4 years, most recently at $1.1 million for Q2 2020.

  • Quarterly Short term Debt rose 40.0% to $1.1 million in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Jun 2020, up 40.0% year-over-year, with the annual reading at $973110.0 for FY2019, 50.0% up from the prior year.
  • Short term Debt was $1.1 million for Q2 2020 at Vycor Medical, roughly flat from $1.1 million in the prior quarter.
  • Over five years, Short term Debt peaked at $1.1 million in Q1 2020 and troughed at $549370.0 in Q4 2017.
  • The 4-year median for Short term Debt is $810925.0 (2019), against an average of $853945.6.
  • Year-over-year, Short term Debt grew 18.09% in 2018 and then soared 50.0% in 2019.
  • A 4-year view of Short term Debt shows it stood at $549370.0 in 2017, then increased by 18.09% to $648740.0 in 2018, then soared by 50.0% to $973110.0 in 2019, then increased by 16.67% to $1.1 million in 2020.
  • Per Business Quant, the three most recent readings for VYCO's Short term Debt are $1.1 million (Q2 2020), $1.1 million (Q1 2020), and $973110.0 (Q4 2019).